Atara Biotherapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (24)

Latest Posts

About This Stock More About This Stock
Atara Jumps After Data Released On Multiple Sclerosis Study
Article By: The Fly
Saturday, May 23, 2020 3:19 PM EDT
Data to be presented at the virtual European Academy of Neurology meeting next week in a late-breaking abstract related to ATA188, an allogeneic cell therapy being developed by Atara Biotherapeutics, has been released.
In this article: ATRA
Read
Trade Deal Optimism Fuels Santa Rally: ETFs & Stocks To Bet On
Article By: Sweta Killa
Wednesday, December 25, 2019 3:56 AM EDT
Wall Street bulls are currently enjoying a festive rally, driven by positive developments on the trade front and easy money policies.
In this article: ODP, SPHB, BOOT, NKTR, PDP, MTUM, ATRA, ONEO
Read
Atara: The Silver Bullet For Multiple Sclerosis
Article By: Dr. Hung Tran
Thursday, August 1, 2019 12:05 AM EDT
The firm will report Phase 3 results for its lead franchise tab-cell this year. The positive outcomes will erase doubt and fear regarding the departure of senior management.
In this article: ATRA
Read
Weighing The Week Ahead: What Determines The Agenda For Investment News?
Article By: Jeff Miller
Sunday, May 19, 2019 11:00 AM EDT
The economic calendar is one of the lightest, and a long holiday weekend impends. We should all be asking: What determines the agenda for investment news?
In this article: JWN, MMM, THD, ATRA, DFS
Read
Biotech Stocks Emerge Unscathed And Ready To Go
Article By: Tarun Chandra, CFA
Friday, May 18, 2018 8:41 PM EDT
The biotech stocks have been demonstrating strong resilience in the face of intense volatility since February and, remarkably, keeping pace with the broader indexes, considering the highly speculative and volatile nature of the group.
In this article: CVS, MRK, IBB, INCY, ESRX, XBI, ARNA, ECYT, IMMU, IRWD, DVAX, SUPN, SRPT, AGIO, QURE, HRTX, LOXO, ATRA, BGNE, ADAP, CRSP, CBIO, GTHX, MRTX
Read

Latest Tweets for $ATRA

No tweets yet!

PARTNER HEADLINES